ISCO.US International Stem Cell Corp

Healthcare Biotechnology USA Stocks
0.1600 USD
Close of Nov 13, 2026
0.1200 0.5400
Market cap
USD 1.28M
P/E
-
P/B
1.56x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is ISCO.US undervalued?

Graham number

The Graham number of International Stem Cell Corp cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

International Stem Cell Corp fundamental analysis

No fundamental analysis for International Stem Cell Corp yet.

International Stem Cell Corp stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About International Stem Cell Corp

International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally. It develops ISC-hpNSC, a neural stem cell program that has completed the Phase I clinical trial for the treatment of Parkinson's disease, as well as for treating stroke, traumatic brain injury, and Alzheimer's disease. The company offers anti-aging skin care products, including …

Full company profile